Back to results
US 8,748,370 B2Granted
Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
AssigneeStrongbone AB
InventorsAnders Grubb, Franciszek Kasprzykowski, Ulf Lerner, Beata Zolnowska, Regina Kasprzykowska
Life of this patent
Estimating the term…
Abstract
Novel compounds which may be for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation, bone resorption, or loosening of a prosthetic device.
Claims12
A compound of the general formula (I)
- R1-A-NH—CH(R2)—CO—R3 (I)
- wherein,
- R1 is Ar—X—, where X is (CH2)m—O—CO;
- (CH2)m—SO2—CH═CH—CO;
- CH═CH—CO;
- CO-oxirane-CO;
- CO—CH═CH—CO;
- CH2—CH═CH—CO;
- or (CH2)m—CO;
- R1 is NH2—C(NH)—NH—(CH2)m—CO;
- or
- R1 is an acyl residue containing hydroxylated coumarin moiety;
- A is a bond or is one or more of Val or Leu;
- R2 is isopropyl or isobutyl;
- R3 is NH—(CH2)m—NH—C(NH)—NH2;
- R3 is Phe-NH2;
- or
- R3 is NH—CH(R4)—(CH2)m—NH-D, where R4 is C1-C6-alkyl, and D is CO—CH═CH—Ar, CO—CH═CH—SO2—(CH2)m—Ar, or Cum-Phe-, where Cum is an acyl residue containing hydroxylated coumarin moiety;
- Ar is aryl or heteroaryl;
- and
- m is an integer of 0 to 5;
- the compound as a single stereoisomer or a mixture of different stereoisomers, or a pharmaceutically acceptable salt thereof.
19 more elements
Dependencies are inferred from the claim text.